Determination of Catheter Contact by Evaluation of Microelectrode Near-Field Signals
| Status: | Completed |
|---|---|
| Conditions: | Atrial Fibrillation, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2014 |
| End Date: | December 2015 |
Successful radio frequency (RF) cardiac catheter ablation requires the creation of lesions
by delivering energy while maintaining adequate catheter contact with the endocardium.
Unfortunately, it is difficult to identify contact intraoperatively as a typical RF ablation
catheter lacks clear indications of contact. We propose to use the Boston Scientific
IntellaTip MiFi catheter to explore whether characteristics of the electrograms produced by
the mini-electrodes on the ablation tip could help confirm tissue contact. Using an
ultrasound catheter to define instances of clear contact and non-contact, we will determine
whether the micro-electrodes produce sufficient information to confirm catheter contact. We
propose that the MiFi catheter produces sufficient signal characteristics that can be used
as an effective surrogate for adequate tissue contact.
by delivering energy while maintaining adequate catheter contact with the endocardium.
Unfortunately, it is difficult to identify contact intraoperatively as a typical RF ablation
catheter lacks clear indications of contact. We propose to use the Boston Scientific
IntellaTip MiFi catheter to explore whether characteristics of the electrograms produced by
the mini-electrodes on the ablation tip could help confirm tissue contact. Using an
ultrasound catheter to define instances of clear contact and non-contact, we will determine
whether the micro-electrodes produce sufficient information to confirm catheter contact. We
propose that the MiFi catheter produces sufficient signal characteristics that can be used
as an effective surrogate for adequate tissue contact.
Inclusion Criteria:
- Subject has a diagnosis of typical atrial flutter
- Subject is clinically indicated for right sided atrial flutter ablation
- Patient is willing and able to understand and sign the informed consent document
- Patient is over 18 years of age
- Patient is willing and able to comply with the study protocol
Exclusion Criteria:
- Patient has one of the following cardiac comorbidities: hypertrophic cardiomyopathy,
structural heart disease, congestive heart failure
- Patient has history of the following arrhythmias: ventricular tachycardia,
ventricular fibrillation, Wolff-Parkinson-White syndrome
- Patient has a contraindication to right atrium ablation, including but not limited
to: right atrial thrombus, active systemic infection, or a coagulopathy.
We found this trial at
2
sites
Emory University Hospital Midtown Emory University Hospital Midtown is a 511-bed community-based, acute care teaching...
Click here to add this to my saved trials
Click here to add this to my saved trials